High throughput T epitope mapping and vaccine development.

Mapping of antigenic peptide sequences from proteins of relevant pathogens recognized by T helper (Th) and by cytolytic T lymphocytes (CTL) is crucial for vaccine development. In fact, mapping of T-cell epitopes provides useful information for the design of peptide-based vaccines and of peptide libr...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Biomedicine & Biotechnology pp. 12p - 13
Autores principales: Li Pira G, Ivaldi F, Moretti P, Manca F
Formato: review tables/charts Journal Article
Publicado: Wiley-Blackwell 2010
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105082237&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105082237
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11107243
        137K
      jtl: Journal of Biomedicine & Biotechnology
      issn: 11107243
      maglogo: N
    pubinfo:
      dt: 2010
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        105082237
        2010748592
        10.1155/2010/325720
        NLM20617148
        PMC2896667
        105082237
      ppf: 12p
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: High throughput T epitope mapping and vaccine development.
      aug:
        au:
          Li Pira G
          Ivaldi F
          Moretti P
          Manca F
        affil: Laboratory of Cellular Immunology, Advanced Biotechnology Center, 16132 Genoa, Italy. lipira@email.it
      sug:
        subj:
          Antigens
          Immunologic Tests
          Vaccines
          Costs and Cost Analysis
          Lymphocytes
          Peptides
          Proteins
          T Lymphocytes
          Time Factors
          Workload
      ab: Mapping of antigenic peptide sequences from proteins of relevant pathogens recognized by T helper (Th) and by cytolytic T lymphocytes (CTL) is crucial for vaccine development. In fact, mapping of T-cell epitopes provides useful information for the design of peptide-based vaccines and of peptide libraries to monitor specific cellular immunity in protected individuals, patients and vaccinees. Nevertheless, epitope mapping is a challenging task. In fact, large panels of overlapping peptides need to be tested with lymphocytes to identify the sequences that induce a T-cell response. Since numerous peptide panels from antigenic proteins are to be screened, lymphocytes available from human subjects are a limiting factor. To overcome this limitation, high throughput (HTP) approaches based on miniaturization and automation of T-cell assays are needed. Here we consider the most recent applications of the HTP approach to T epitope mapping. The alternative or complementary use of in silico prediction and experimental epitope definition is discussed in the context of the recent literature. The currently used methods are described with special reference to the possibility of applying the HTP concept to make epitope mapping an easier procedure in terms of time, workload, reagents, cells and overall cost.
      pubtype: Academic Journal
      doctype:
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N